Emerging biotechnologies: full report - Nuffield Council on Bioethics

More documents

Recommendations

Info

E m e r g i n g b i o t e c h n o l o g i e s 2. To provide data and concrete examples to support this analysis 3. To assist the Working Party to draw conclusions about how decisions about IP conditions that influence (limit, facilitate, control, direct, etc.) the emergence of <strong>biotechnologies</strong> should be framed and advice that should be taken into consideration. The review was carried out by Dr Siva Thambisetty, London School of Economics and Political Science and was informed by work on an EPSRC Discipline Hopping Award on synthetic biology. The review was largely based on secondary research. External review An earlier version of this Report was reviewed by 12 individuals with expertise in disciplines relevant to different aspects the project. These individuals were: ■ Dr Tavis Bayer ■ Professor Julia Black ■ Professor Martin Bobrow ■ Professor John Dupré ■ Dr Yasemin J Erden ■ Dr Shawn Harmon ■ Professor Stephen Hughes ■ Professor Sheila Jasanoff ■ Dr Paul Nightingale ■ Professor Judith Petts ■ Professor Dietram A Scheufele ■ Professor Philip Scranton The Working Party deeply appreciates the time and thought the reviewers brought to this task and thanks them for their helpful contributions. The views expressed within this Report are those of the Working Party and the <strong>Council</strong> and do not necessarily reflect the views of any participants in the various activities undertaken by the Working Party in connection with this Report. 182
E m e r g i n g b i o t e c h n o l o g i e s Appendix 2: Wider consultation for the Report The aim of the consultation was to obtain views from as wide a range of organisations and individuals interested in the area as possible. The consultation document was published online and made available in hard copy on request. Individuals and organisations that the Working Party expected to have a particular interest were also directly alerted by email and encouraged to respond. The document was divided into three main substantive parts: ■ ■ ■ the nature and identity of emerging technologies; the cultural, international and historical context; and the relevant ethical, policy and public engagement issues. In total, 17 questions were posed, and respondents were encouraged to answer as many, or as few, as they wished. Eighty four responses were received, 48 from individuals and 36 from organisations. Eight respondents wished to remain anonymous. All the responses were circulated to Working Party members and a summary of responses was considered in detail at a subsequent Working Party meeting. A summary of the responses received, together with the original consultation paper, is available on the <strong>Council</strong>'s website. 706 Individual responses will also be published in <strong>full</strong> on the website, where respondents have given permission for the <strong>Council</strong> to do so. The responses received played an important role in shaping the Working Party's thinking, and the Working Party is grateful to all those who contributed. Anonymous Eight respondents wished to remain unlisted. Individuals ■ Professor Jayapaul Azariah, Founder President, All India Bioethics Association ■ S. Bonny ■ Professor Derek Burke ■ Professor Raphael Cohen-Almagor, University of Hull ■ Mr K.R Coleman ■ Dr Otakar Fojt, Science and Innovation Network, British Embassy Prague ■ Dr Sara Fovargue, Law School, Lancaster University ■ Dr Caroline E Foster ■ Dr Christopher French ■ Professor Robert T Hall, Profesor de Bioética, Facultad de Química, Universidad Autónoma de Querétaro, Mexico ■ Dr Olivia Harvey ■ Jonathan Harwood ■ Elisabeth Hildt, University of Mainz ■ Yutaka Hishiyama A P P E N D I X 2 : W I D E R C O N S U L T A T I O N F O R T H E R E P O R T 706 See: http://www.nuffieldbioethics.org/emerging-<strong>biotechnologies</strong>/emerging-<strong>biotechnologies</strong>-consultation. 183
Page 1 and 2:
Emerging b
Page 3:
Emerging b
Page 6 and 7:
Secretariat Hugh Whittall (Director
Page 9:
Foreword 1 The use of living organi
Page 13:
Terms of reference 1. To examine co
Page 16 and 17:
Applying public ethics: towards a p
Page 19 and 20:
E m e r g i n g b i o t e c h n o l
Page 21 and 22:
Page 23 and 24:
Page 25 and 26:
Page 27 and 28:
Page 29:
Page 32 and 33:
Page 35:
Part 1 Understanding emerging <stro
Page 38 and 39:
Page 40 and 41:
Page 42 and 43:
Page 44 and 45:
Page 46 and 47:
Page 48 and 49:
Page 51 and 52:
Chapter 2 Biotechnology promises an
Page 53 and 54:
Page 55 and 56:
Page 57 and 58:
Page 59 and 60:
Page 61 and 62:
Page 63 and 64:
Page 65 and 66:
Page 67 and 68:
Page 69 and 70:
Chapter 3 The threefold challenge o
Page 71 and 72:
Page 73 and 74:
Page 75 and 76:
Page 77 and 78:
Page 79 and 80:
Page 81 and 82:
Page 83:
Page 86 and 87:
Page 88 and 89:
Page 90 and 91:
Page 92 and 93:
Page 94 and 95:
Page 96 and 97:
Page 98 and 99:
Page 100 and 101:
Page 102 and 103:
Page 105 and 106:
Chapter 5 Public perspectives
Page 107 and 108:
Page 109 and 110:
Page 111 and 112:
Page 113 and 114:
Page 115 and 116:
Page 117 and 118:
Page 119 and 120:
Page 121 and 122:
Page 123 and 124:
Chapter 6 Research
Page 125 and 126:
Page 127 and 128:
Page 129 and 130:
Page 131 and 132:
Page 133 and 134:
Page 135 and 136:
Page 137 and 138:
Page 139 and 140:
Page 141:
Page 144 and 145:
Page 146 and 147:
Page 148 and 149:
Page 150 and 151:
Page 152 and 153:
Page 154 and 155:
Page 156 and 157:
Page 158 and 159:
Page 160 and 161:
Page 162 and 163: E m e r g i n g b i o t e c h n o l
Page 181 and 182: Chapter 9 Commercialisation
Page 203 and 204: Chapter 10 Conclusions: emerging <s
Page 209 and 210: Appendices
Page 211: E m e r g i n g b i o t e c h n o l
Page 239: Previous Nuffield
show all

Emerging biotechnologies: full report - Nuffield Council on Bioethics

Create successful ePaper yourself

Delete template?

Save as template?